EGFR inhibition decreases SLC2A1, HK2, and c-Myc gene expression (Makinoshima et al., 2014), and GLUT1, HK2, c-Myc, and HIF-1α protein expression in human NSCLC cells (Momcilovic et al., 2017). This evidence concerns the gene SLC2A1 and non-small cell lung carcinoma.